Roche
RO.SW
#33
Rank
A$587.90 B
Marketcap
A$737.86
Share price
-0.64%
Change (1 day)
22.75%
Change (1 year)

Roche (RO.SW) - P/B ratio

P/B ratio as of November 2026 : 8.62

According to Roche's latest financial reports the company has a price-to-book ratio of 4.89144.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Roche - P/B ratio (from 2006 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-316.9122.04%
2024-12-315.66-4.39%
2023-12-315.92-20.89%
2022-12-317.49-31.12%
2021-12-3110.963.94%
2020-12-316.63-11.14%
2019-12-317.469.38%
2018-12-316.82-5.88%
2017-12-317.25-3.86%
2016-12-317.54-25.41%
2015-12-3110.1-4.83%
2014-12-3110.66.79%
2013-12-319.95-42.13%
2012-12-3117.280.01%
2011-12-319.55-6.51%
2010-12-3110.2-37.55%
2009-12-3116.4523.59%
2008-12-312.62-18.28%
2007-12-313.21-29.63%
2006-12-314.56

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.89-8.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
7.60-11.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.84-78.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.41-60.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
20.3 135.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.39-83.84%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
2.37-72.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
7.80-9.55%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3.94-54.35%๐Ÿ‡ฌ๐Ÿ‡ง UK